News & Events :: Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN

Recent NewsView All News

Apr 3, 2023 8:50am EDT

Alzamend Neuro Announces the Initiation of a Phase I/IIA Trial for Its Immunotherapy Vaccine (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type

Mar 22, 2023 8:00am EDT

Alzamend Neuro Announces Completion of Clinical Portion of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Recent Events View All Events

April 26, 2023 12:00 pm EDT

2023 Annual Meeting of Stockholders

View All Events

Latest Presentation View All Presentations

Corporate Presentation

View All Presentations

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings